Stocks
Intellia Therapeutics (NTLA) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -261.0 | -450.6 | -506.3 | -524.0 | -396.8 | -417.6 | ||
| Changes by years, y/y, % | +100% | +73% | +12% | +3% | -24% | +25.0% | |||
Intellia Therapeutics. EBITDA US GAAP, bln rub
Intellia Therapeutics. EBITDA US GAAP, changes, %
Intellia Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Intellia Therapeutics (NTLA) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA, bln rub | ? | -133.9 | -118.3 | -107.5 | -96.4 | -95.4 | -417.6 | |
| Changes by years, y/y, % | -3% | +6% | -21% | -32% | -29% | |||
| Changes by quarters, q/q, % | -6% | -12% | -9% | -10% | -1% | |||
